|
Volumn 91, Issue 12, 2000, Pages 1333-1338
|
Improved in vivo antitumor efficacy and reduced systemic toxicity of carboxymethylpullulan-peptide-doxorubicin conjugates
a a a a a |
Author keywords
Carboxymethylpullulan; Doxorubicin; Enhanced permeability and retention; Polymeric drug
|
Indexed keywords
ANTIMETASTATIC AGENT;
ANTINEOPLASTIC AGENT;
DOXORUBICIN;
DOXORUBICIN DERIVATIVE;
DRUG CARRIER;
DRUG VEHICLE;
GLYCINE;
HYDROXYL GROUP;
LEUCINE;
MALTOTRIOSE;
N (2 HYDROXYPROPYL)METHACRYLAMIDE;
PHENYLALANINE;
PLASMA SUBSTITUTE;
POLYMER;
PULLULAN;
SODIUM CHLORIDE;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
CANCER SURVIVAL;
CONTROLLED STUDY;
DOSE RESPONSE;
DRUG CONJUGATION;
DRUG EFFICACY;
DRUG MIXTURE;
DRUG STRUCTURE;
FEMALE;
IN VIVO STUDY;
LEUKEMIA;
LUNG CARCINOMA;
METASTASIS INHIBITION;
MOUSE;
NONHUMAN;
PRIORITY JOURNAL;
RETICULOSARCOMA;
TOXICITY TESTING;
TUMOR MODEL;
TUMOR REGRESSION;
WEIGHT REDUCTION;
|
EID: 0034526074
PISSN: 09105050
EISSN: None
Source Type: Journal
DOI: 10.1111/j.1349-7006.2000.tb00922.x Document Type: Article |
Times cited : (12)
|
References (13)
|